Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition(s):Polycystic Kidney DiseaseLast Updated:February 11, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Polycystic Kidney DiseaseLast Updated:February 11, 2019Completed
Condition(s):Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeLast Updated:June 22, 2021Recruiting
Condition(s):Polycystic Kidney DiseaseLast Updated:December 1, 2016Completed
Condition(s):Cutaneous Lupus Erythematosus; Systemic Lupus Erythematosus RashLast Updated:February 2, 2021Active, not recruiting
Condition(s):Actinic KeratosesLast Updated:April 22, 2021Completed
Condition(s):Mitochondrial MyopathiesLast Updated:June 4, 2019Completed
Condition(s):PreeclampsiaLast Updated:September 13, 2021Completed
Condition(s):Heart FailureLast Updated:October 28, 2020Terminated
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:January 22, 2020Completed
Condition(s):HypoalphalipoproteinemiaLast Updated:September 13, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.